Table of Contents Table of Contents
Previous Page  27 / 146 Next Page
Information
Show Menu
Previous Page 27 / 146 Next Page
Page Background

verts EPID images to fluence and a pencil beam algorithm to calculate the

dose. It can be used for pretreatment QA verification and for in vivo do-

simetry. In this work we evaluated the suitability of DC software for VMAT

verifications.

Materials and methods:

DC (v4.10) was used along with Elekta Synergy®

Linac (6 and 10 MV beams) equipped with a-Si electronic portal imaging

device (EPID) Iview-GT. Twenty VMAT (5 prostate, 5 whole pelvis, 5 lung,

5 head and neck), elaborated by treatment planning system (TPS) Elekta

Monaco® 5.0, were measured. Through-air (EPID T-A) and transit EPID

images were used for three dimensional dose map reconstruction in ho-

mogeneous phantoms. Octavius 4D with 729 2D array was used as a

reference. Gamma analysis at 3% local dose/3 mm DTA was performed. Doses

from though-air measurements were also reconstructed in the planning

CT (T-A in plan TC) and compared with the treatment planning dose maps.

Gamma pass rate of DC dose maps was compared with those of 729 in the

Octavius 4D.

Results:

The assessment of VMAT plans shows a mean of 93.9% points with

gamma

<

1 for Octavious 4D (3.5% SD), 89.2% and 7.9% SD for EPID T-A, 89%

and 8.5% SD for EPID transit and 89.8% and 6.1% SD for T-A in plan CT. Transit

andthrough-airEPIDacquisitionsproducedsimilargammapassrates.Through-

air EPID images computed by DC in the planning CT showed gamma pass

rate in agreement with those of Octavious 4D in the prostate, whole pelvis

and head and neck, in lung instead, gamma pass rates were lower in 4/5 cases.

Conclusions:

DC is a suitable tool for VMAT verifications. The pencil beam

algorithm can be inaccurate in the presence of low-density inhomogeneities.

http://dx.doi.org/10.1016/j.ejmp.2016.01.076

A.73

CHARACTERIZATION OF HIGH-DOSE-PER-PULSE INTRAOPERATIVE

RADIATION THERAPY ELECTRON BEAMS BY USING A MICRODIAMOND

DOSIMETER

M. Falco

* , a ,

M. Marinelli

b ,

A. Tonnetti

b ,

G. Verona Rinat

i b ,

M. Pimpinella

c ,

A. Ciccotelli

d ,

S. De Stefano

d ,

G. Felici

d ,

F. Marangoni

d .

a

Department of

Radiation Oncology G. D’Annunzio, Università di Chieti SS. Annunziata Hospital,

Chieti, Italy;

b

INFN – Dipartimento di Ingegneria Industriale, Università di Roma

Tor Vergata, Via del Politecnico 1, 00133, Roma, Italy;

c

Istituto Nazionale di

Metrologia delle Radiazioni Ionizzanti, ENEA-INMRI C R Casaccia, Roma, Italy;

d

SIT – Sordina IORT Technologies S.p.A., Aprilia, Italy

Purpose:

Accurate clinical dosimetry of electron beams produced by linear

accelerators dedicated to intraoperative radiation therapy (IORT) is chal-

lenging due to the very high dose-per-pulse (0.3–10 cGy per pulse) as

compared to conventional accelerators (

<

0.01 cGy per pulse). The aim of

this work is to characterize electron beams produced by a dedicated mobile

accelerator for IORT by using the microDiamond 60019 PTW Freiburg

dosimeter.

Materials and methods:

A dosimetric characterization of electron beams

produced by a NOVAC11 IORT accelerator (S.I.T. – Sordina IORT Technolo-

gies) in the 6–9 MeV energy range, with dose rate from 26 to 105 mGy per

pulse, was performed. The response of the mD was first tested in terms

of dose linearity. Percentage depth dose (PDD) curves, beam profiles and

output factors were then measured and compared with those obtained by

an Advanced Markus ionization chamber (AM-IC), previously character-

ized for measurements in high dose per pulse electron beams, and a PTW

silicon diode E (Si-D).

Results:

The microDiamond showed a linear dose response, independent

of dose per pulse, in the dose range from 0.2 Gy to 28 Gy. PDD measure-

ments were found in agreement with the ones obtained by using the AM-

IC and Si-D, with differences in R50 values below 0.3 mm. Profile

measurements evidenced a high spatial resolution of the mD, slightly worse

than the one of the silicon diode, being the differences in penumbra values

no larger than 0.5 mm. OFs measured by the mD were found to be within

2% with respect to those obtained by the AM-IC, in field sizes down to 3 cm

in diameter.

Conclusions:

The performed dosimetric tests evidenced that the

microDiamond dosimeter is suitable for accurate relative dosimetry in high

dose per pulse IORT electron beams.

http://dx.doi.org/10.1016/j.ejmp.2016.01.077

A.74

COMPARISON BETWEEN 2D AND 3D IMRT PRE-TREATMENT

VERIFICATION

Y.A.C. Fiagan

* , a ,

F. Simonato

b ,

A. Roggio

b ,

M.A. Rossato

b ,

A. Scaggion

b ,

R. Zandonà

b ,

M. Paiusco

b .

a

ICTP – Abdus Salam International Centre for

Theoretical Physics, Trieste, Italy;

b

Istituto Oncologico Veneto IOV – IRCCS,

Padova, Italy

Introduction:

Patient-specific pretreatment verification of intensity modu-

lated radiation therapy (IMRT) treatments can be performed using software

that modifies the dose distribution calculated by the treatment planning

system (TPS) according to the dose discrepancies detected during dosim-

etry measurements. The aim of this work is to investigate the sensitivity

of patient-related gamma analysis and DVH-based metrics to the geome-

try of the dosimeter used as verification system.

Materials and methods:

10 prostate and 10 H&N cases were planned with

IMRT technique. Pre-treatment verifications were performed by acquir-

ing planar per-beam dose distributions with MapCHECK and cumulative

dose distributions with ArcCHECK. TPS dose distributions were com-

pared to the dose distributions reconstructed by 3DVH software via

MapCHECK and ArcCHECK measurements. 2D gamma analysis in phantom

geometry, 3D gamma analysis in patient geometry and patient-specific DVH

metrics were used to assess the dosimetric accuracy.

Results:

Planar per-beam 2D dosimetry is shown to produce generally larger

gamma passing rate (PR%) than composite pseudo-3D cylindrical dosim-

etry. Similarly, 3D gamma analysis based on planar measurements yielded

larger PR% values than that based on cylindrical measurements. In general

5%

±

3.5% larger PR% is found when using 3D instead of 2D analysis. DVH

analysis revealed generally small differences between TPS dose distribu-

tion and 3DVH dose distribution for both dosimetric systems. DVH variations

based on cylindrical measurement are found to be generally larger than

that coming from planar dosimetry, but no statistically significant devia-

tion from TPS DVH is found.

Conclusions:

A pseudo-3D dosimeter is preferable to a planar one if gamma

metric is chosen to evaluate delivery accuracy IMRT pre-treatment veri-

fication. Conversely, the geometry of the dosimeter does not affect DVH-

related metric as obtained from 3DVH software and the two dosimeters

can be considered equivalent.

http://dx.doi.org/10.1016/j.ejmp.2016.01.078

A.75

PATIENT SPECIFIC CBCT CALIBRATION FOR DOSIMETRIC EVALUATION OF

HYBRID RT-PLAN

A. Fidanzio

*

, a ,

S. Menn

a a ,

F. Grec

o a ,

L. Azario

a ,

A. Porcelli

a ,

G. Benecchi

b ,

A. Piermattei

a .

a

U.O.C. Fisica Sanitaria UCSC, Roma, Italy;

b

UO di Fisica

Sanitaria Azienda Ospedaliaro-Universitaria, Parma, Italy

Introduction:

Several factors such as patient setup and the anatomical

changes can affect the dose delivery in radiotherapy. The cone beam CT

(CBCT) allows a timely assessment of the treatment and its calibration, in

terms of relative electron densities (RED), allows hybrid plan calculation

useful to adopt an adaptive strategy. However the CBCT calibration suffers

from some problems such as time stability and patient variability. This work

reports the dosimetric assessment of an original patient-specific CBCT cal-

ibration method.

Methods and materials:

An automated procedure was adopted to cali-

brate CBCT images in terms of RED adopting the following steps: (1) two

CT and CBCT scans with negligible morphological changes are selected for

a patient, (2) in these images the HU values of different ROIs, relative to

correspondent anatomical regions, are acquired to obtain a correlation func-

tion between CBCT and CT HUs, (3) the correlation function is used to

determine the CBCT calibration curve HUs versus RED from the CT cali-

bration curve; (4) finally the CBCT calibration curve is optimized by an

algorithm that minimizes the differences in the patient’s radiological thick-

nesses measured on the CT and CBCT patient’s slices. The procedure has

been verify for H&N, lung and pelvic body regions in Rando phantom and

for 15 VMAT patients irradiated by a linac Varian TrueBeam STx. Using

Eclipse TPS the dosimetric assessment of the method was based on: the

ratio between isocenter doses; the gamma analysis between the dose ma-

trices of planes passing through the isocenter and DVH comparisons.

e22

Abstracts/Physica Medica 32 (2016) e1–e70